HH
Schedule 13G filing
HBM Healthcare Investments (Cayman) Ltd. disclosed a 8% stake in Vicore Pharma Holding AB (VCRE)
HBM Healthcare Investments (Cayman) Ltd. reported owning 8% of Vicore Pharma Holding AB (VCRE) (22,505,819 shares) in a Schedule 13G filed Oct 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 13, 2026
- Source
- Schedule 13G
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.